Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Higher serum 25(OH)D was positively associated with OA prevalence in a non-linear fashion, likely reflecting reverse causation or health-seeking behavior (i.e., patients with OA proactively taking vitamin D supplements) rather than a causal harmful effect, consistent with null results from vitamin D supplementation trials for OA.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Association between serum 25-hydroxyvitamin D and osteoarthritis prevalence in US adults: a cross-sectional study using NHANES 2007 to 2023

Source: Article title.

Participants were included if they were aged ≥20 years and had complete data on serum 25(OH)D (LBXVIDMS), self-reported OA (MCQ160A), BMI (BMXBMI), sex (RIAGENDR), race/ethnicity (RIDRETH1), valid MEC sample weights (WTMEC2YR), primary sampling unit (SDMVPSU), and stratum (SDMVSTRA).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between serum 25-hydroxyvitamin D and osteoarthritis prevalence in US adults: a cross-sectional study using NHANES 2007 to 2023

Cross-sectional study · Annals of Medicine and Surgery · 2026

Original publication title

Association between serum 25-hydroxyvitamin D and osteoarthritis prevalence in US adults: a cross-sectional study using NHANES 2007 to 2023

Ibrahim Khalil; Mohammed Hrebat; Nadjet Laouadi; Ahmed Osman Hassan Ali; Tareq Albaqali; Mahmoud Ali Khazbak; Meera Abu Eisheh; Mahmoud Raed Sarahen; Taher Abuawwad; Farrukh Ameer; Bilal Aqel; Mohammad Hujeirat; Manar Atrash; Noor Nader Rashed; Ahmed Abdelsamad

Copyright © 2026 The Author(s). Published by Wolters Kluwer Health, LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Osteoarthritis (OA) is a leading cause of chronic disability globally, and the role of vitamin D in OA pathogenesis remains controversial. This cross-sectional study analyzed data from 35 887 US adults aged ≥20 years across seven NHANES cycles (2007 to 2023), all using standardized LC-MS/MS for serum 25-hydroxyvitamin D [25(OH)D] measurement. Survey-weighted logistic regression, restricted cubic splines (RCS), subgroup analyses with interaction testing, E-value assessment, Baron: Kenny CRP mediation analysis, and temporal trend evaluation were performed. The survey-weighted OA prevalence was 26.2%. In the fully adjusted model, each 10 nmol/L increase in 25(OH)D was associated with 5.3% higher odds of OA (OR = 1.053; 95% CI: 1.037 to 1.069; P < 0.001).

RCS analysis revealed a threshold effect above 50 nmol/L, plateauing at 100 to 125 nmol/L. Significant effect modification was observed by age (P < 0.001) and BMI (P = 0.004), with the strongest association among obese adults (OR = 1.058). CRP did not mediate the association (−4.7%). The E-value was 1.29. Results were robust across seven sensitivity analyses and consistent across all survey cycles (ORs: 1.032 to 1.088). Higher serum 25(OH)D was positively associated with OA prevalence in a non-linear fashion, likely reflecting reverse causation or health-seeking behavior (i.e., patients with OA proactively taking vitamin D supplements) rather than a causal harmful effect, consistent with null results from vitamin D supplementation trials for OA.

Authors’ abstract

Osteoarthritis (OA) is a leading cause of chronic disability globally, and the role of vitamin D in OA pathogenesis remains controversial. This cross-sectional study analyzed data from 35 887 US adults aged ≥20 years across seven NHANES cycles (2007 to 2023), all using standardized LC-MS/MS for serum 25-hydroxyvitamin D [25(OH)D] measurement. Survey-weighted logistic regression, restricted cubic splines (RCS), subgroup analyses with interaction testing, E-value assessment, Baron: Kenny CRP mediation analysis, and temporal trend evaluation were performed. The survey-weighted OA prevalence was 26.2%. In the fully adjusted model, each 10 nmol/L increase in 25(OH)D was associated with 5.3% higher odds of OA (OR = 1.053; 95% CI: 1.037 to 1.069; P < 0.001).

RCS analysis revealed a threshold effect above 50 nmol/L, plateauing at 100 to 125 nmol/L. Significant effect modification was observed by age (P < 0.001) and BMI (P = 0.004), with the strongest association among obese adults (OR = 1.058). CRP did not mediate the association (−4.7%). The E-value was 1.29. Results were robust across seven sensitivity analyses and consistent across all survey cycles (ORs: 1.032 to 1.088). Higher serum 25(OH)D was positively associated with OA prevalence in a non-linear fashion, likely reflecting reverse causation or health-seeking behavior (i.e., patients with OA proactively taking vitamin D supplements) rather than a causal harmful effect, consistent with null results from vitamin D supplementation trials for OA.

Publication and source details

Original title: Association between serum 25-hydroxyvitamin D and osteoarthritis prevalence in US adults: a cross-sectional study using NHANES 2007 to 2023

Ibrahim Khalil; Mohammed Hrebat; Nadjet Laouadi; Ahmed Osman Hassan Ali; Tareq Albaqali; Mahmoud Ali Khazbak; Meera Abu Eisheh; Mahmoud Raed Sarahen; Taher Abuawwad; Farrukh Ameer; Bilal Aqel; Mohammad Hujeirat; Manar Atrash; Noor Nader Rashed; Ahmed Abdelsamad

Annals of Medicine and Surgery · 2026

* Corresponding author. Address: Department of Emergency Medicine, Red Crescent Specialized Hospital, Nemra/Halhul Street, P.O. Box 25, Hebron 90100, Palestine. Tel.: +970 59-9000000; +20 1141579270. E-mail: ietfeiheh2016@gmail.com (I. Khalil).Copyright © 2026 The Author(s). Published by Wolters Kluwer Health, LLC.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-08T11:18:01+00:00

DOI: 10.1097/ms9.0000000000005552 · PMC13657557